AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹3,266 Cr | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹3,266 Cr |
| Mar2024 | ₹2,739 Cr |
| Mar2023 | ₹4,496 Cr |
| Mar2022 | ₹2,938 Cr |
| Mar2021 | ₹2,429 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,266 Cr | 19.22 | |
| Mar2024 | ₹2,739 Cr | -39.08 | |
| Mar2023 | ₹4,496 Cr | 53.07 | |
| Mar2022 | ₹2,938 Cr | 20.94 | |
| Mar2021 | ₹2,429 Cr | - | |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹71,798.5 Cr | 2.6% | 12.4% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,160.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,288.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,440.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,149.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,369.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 2.6% |
12.4% |
-1% |
| SENSEX | 0.1% |
1.1% |
8.4% |
You may also like the below Video Courses